|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| ASSETS | |||
| Current assets | |||
| Cash equivalents | |||
| Due from Sponsor | |||
| Prepaid expense | |||
| Prepaid insurance | |||
| Total Current Assets | |||
| Deferred offering costs | |||
| Cash and marketable securities held in Trust Account | |||
| TOTAL ASSETS | |||
| Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit: | |||
| Current liabilities | |||
| Accrued expenses | |||
| Accrued offering costs | |||
| Promissory note – related party | |||
| Total Current Liabilities | |||
| Deferred underwriting fee payable | |||
| Total Liabilities | |||
| Class A Ordinary Shares subject to possible redemption, 17,250,000 and 0 shares at redemption value of $10.14 and $0 per share as of June 30, 2026 and December 31, 2025, respectively | |||
| Shareholders’ Deficit | |||
| Common stock value | |||
| Common Class B | |||
| Class A Ordinary Shares | |||
| Class B Ordinary Shares | |||
| Additional paid-in capital | |||
| Accumulated deficit | |||
| Total Shareholders’ Deficit | |||
| Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
Loading...
